Omkar Speciality Chemicals Limited · NSE:OMKARCHEM
Omkar Speciality Chemicals — Q3 FY2019 Earnings Presentation
27 slides from Omkar Speciality Chemicals's earnings presentation, 2019
Slide 1: Investor Presentation Q3FY2019
INVESTOR PRESENTATION Q3FY2019 © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE & CONFIDENTIAL. NOT FOR CIRCULATION
Slide 2: Table of Content
TABLE OF CONTENT 1 ABOUT OSCL 2 PERFORMANCE NUGGETS (Q3FY19) 3 BUSINESS PERFORMANCE 4 MANUFACTURING ATTRIBUTES 5 STRATEGIC EVOLUTION 6 KEY GROWTH LEVERS 7 MARKET SCENARIO 8 MANAGEMENT © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE & CONFIDENTIAL. NOT FOR CIRCULATION
Slide 3: Safe Harbour
SAFE HARBOUR This presentation and the accompanying slides (the “Presentation”), which have been prepared by OMKAR SPECIALITY CHEMICALS LIMITED ‘OSCL’ (the “Company”) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securi
Slide 4: Business Contour
BUSINESS CONTOUR SALES GEOGRAPHY (Q3FY19) • Omkar Speciality Chemicals Limited (OSCL) is a vertically integrated group spanning the entire speciality chemicals and pharma value chain, with established credentials in complex chemistry, research & development, manufacturing and global marketing • Pion
Slide 5: Key P&L Ratios
KEY P&L RATIOS 9MFY19 BREAK UP SALES % IN % 85.4 58.41 71.6 43.25 39.37 54.57 12.64 4.11 45.43 -7.91 28.4 -16.27 14.6 -63.07 -72.1 Domestic Exports Gross Margin EBITDA Margin PAT Q1FY19 Q2FY19 Q3FY19 Q1FY19 Q2FY19 Q3FY19 © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE & CONFIDENTIAL. NOT FOR
Slide 6: Key P&L Ratios
KEY P&L RATIOS 9MFY19 BREAK UP IN % 3.38 0.13 0.13 0.13 0.1 0.08 0.07 -2.34 -4.78 -4.55 -6.02 -6.89 -1.54 -1.47 -1.52 Debt Equity Current Ratio Asset turnover ratio % ROC ROCE (No of times) (No of times) Q1FY19 Q2FY19 Q3FY19 Q1FY19 Q2FY19 Q3FY19 © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE
Slide 7: Niche Product Applications
NICHE PRODUCT APPLICATIONS © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE & CONFIDENTIAL. NOT FOR CIRCULATION OUR PRODUCTS ARE USED FOR APPLICATIONS SUCH AS ANTI-DIABETIC, ONCOLOGY, ANTI-INFECTIVES, PHARMA CARDIOVASCULAR AND VARIOUS LIFE SAVING MEDICINES THE PRODUCTS IN THIS SEGMENT ARE USED
Slide 8: Business Segment Wise Revenue
BUSINESS SEGMENT WISE REVENUE 9MFY19 BREAK UP Rs. 18.58 Rs. 1.82 Rs. 8.54 Rs. 1.56 CRORE CRORE CRORE CRORE PHARMA FEED & INDUSTRIAL & FLAVOURS & NUTRITION SPECIALITY FRAGRANCE CHEMICALS © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE & CONFIDENTIAL. NOT FOR CIRCULATION
Slide 9: International Sales Quotient
INTERNATIONAL SALES QUOTIENT Q3FY19 BREAK UP 84.20% 5.92% 0.70% 0.70% 0.01% 3.90% AUSTRALIA SOUTH AMERICA SOUTH AFRICA INDIA ASIA EUROPE © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE & CONFIDENTIAL. NOT FOR CIRCULATION
Slide 10: Corporate Milestones
CORPORATE MILESTONES • Incorporated as a Launched new proprietary firm at product initiatives— Commenced • Listed on BSE and Badlapur (East), Thane Selenium organic operations at NSE District intermediates Unit-II in Badlapur • Received DSIR • Developed import recognition for substitutes— R&D Centre
Slide 11: Key Product Segments
KEY PRODUCT SEGMENTS PHARMA Produce 60 products in the segment FEED & NUTRITION Produce 17 products in the segment FLAVOURS & FRAGRANCE Produce 05 products in the segment COSMECEUTICALS Produce 02 products in the segment INDUSTRIAL & SPEC CHEM Produce 15 products in the segment © OMKAR SPECIALITY CH
Slide 12: Top Products
TOP PRODUCTS TOP SEVEN PRODUCTS CONTRIBUTE TO OUR GROUP’S TOP-LINE SELENIUM RESOLVING COUMARIN SULFIDE AGENTS SELENITES IODOBENZOIC IODATES & ACIDS IODIDES PERIODATES © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE & CONFIDENTIAL. NOT FOR CIRCULATION
Slide 13: Market Overview
MARKET OVERVIEW Globally, the chemical industry sales stood at $4.3 trillion in FY15, of which specialty chemicals including agrochemicals recorded sales of $829 billion, which is 20% of the global chemical industry sales. Industry estimates indicate that the chemical industry is GLOBAL poised to re
Slide 14: Corporate Cornerstones
CORPORATE CORNERSTONES DIVERSE PRODUCT MIX Diverse mix of over 100 niche products, which cater to a wide spectrum of applications, including pharma, glass and ceramics, fragrance & flavours, feed & nutrition, catalysis, etc SUSTAINED GROWTH Our operational efficiency and profitability with steady im
Slide 15: Robust Business Model
ROBUST BUSINESS MODEL ALIGNING INNOVATION.. ACCELERATING GROWTH COST ADVANTAGE R&D TO FULL SCALE • Lean production cost has mitigated • We have fully backward-integrated our pressure on margins manufacturing processes —from gram to • Improved technology and backward full-scale bulk production integr
Slide 16: Our Regulatory Strongpoint
OUR REGULATORY STRONGPOINT DMF 1 APPROVED PRODUCT PATENTS FDA GRANTED STRATEGICALLY 7* BACKWARD INTEGRATED 1 PROCESS APPROVED PATENTS UNIT GLOBAL CERTIFICATIONS 5 CERTIFICATIONS © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE & CONFIDENTIAL. NOT FOR CIRCULATION
Slide 17: Process Patents Granted
PROCESS PATENTS GRANTED 5-IODO-2-METHYLBENZOIC ACID TERMINAL DIHALOALKANE It finds application in New-Gen Anti-Diabetic drug (type-2 diabetes, subtype-2 sodium- 01 05 It finds application in Anti-Diabetic medication (oral hypoglycemic of the dipeptidyl glucose transport (SGLT-2) inhibitors class. pe
Slide 18: Creating Entry Barriers
CREATING ENTRY BARRIERS ROBUST R&D Strong R&D back up leading to IPR REGULATORY APPROVALS Have qualified and experienced regulatory professionals to ensure necessary documentation, licensing and legal compliances before the products are CATALYSTS manufactured Proprietary catalysts which helps in imp
Slide 19: R&D Capabilities
R&D CAPABILITIES R&D Center based in Badlapur is approved by DSIR Quality management by way of reduction of impurity levels Proven capabilities to develop tailor-made products for various clients Innovative processes for new products has led to pioneering status for several of our products Contribut
Slide 20: Prospects for Growth: CRAMS
PROSPECTS FOR GROWTH CONTRACT RESEARCH & MANUFACTURING SERVICES (CRAMS) SKILL SETS CAPABILITIES OSCL has in place advanced technologies, skills, established expertise and facilities to manufacture at full scale. Also have strong ties with the raw 03 04 OSCL has the ability to assist customers with b
Slide 21: Key Growth Drivers
KEY GROWTH DRIVERS QUALITY CAPACITY PROCESS PRODUCT INFRASTRUCTURE EXPANSION TECHNOLOGY OUTREACH Upgrade our quality Capacity expansion across Newer technologies on the Focus on high volume systems and infrastructure all five plants for existing process side to improve intermediates for to comply wi
Slide 22: Our Sustainable Business Model
OUR SUSTAINABLE BUSINESS MODEL Our market knowledge, regulatory expertise, strong reputation and management experience helped us identify niche products Our skilled R&D and regulatory teams develop new products to meet customers’ need, and achieve international approvals and registrations Strong emp
Slide 23: Next Phase of Growth
NEXT PHASE OF GROWTH STRONG PRODUCT DEVELOPMENT VIBRANT MARKET PLATFORM IMPECCABLE MANUFACTURING UNMATCHED & FILING CAPABILITIES CAPABILITY INNOVATION • Filing intensity ramping • Recognized leadership • Four WHO-GMP • Our innovation is up with a focus on position in India accredited plants having b
Slide 24: Global Product Outreach
GLOBAL PRODUCT OUTREACH IODOBENZOIC SELENIUM ADVANCE PHARMA RESOLVING BISMUTH,MOLYBDENU COUNTRY COUMARIN ACID SULFIDE SELENITES SELENATES IODIDES IODATES PERIODATES INTERMEDIATES AGENTS M PRODUCTS AUSTRALIA & NEW ZEALAND ASIA PACIFIC CENTRAL EUROPE RUSSIA & CIS NORTH AMERICA LATIN AMERICA SOUTH AMER
Slide 25: Board of Directors
BOARD OF DIRECTORS PRAVIN H. HERLEKAR He is a B-Tech Chemical Engineer from IIT-(Bom) and a Post Graduate in Business Management. He CHAIRMAN & has an overall experience of 40-years in the niche chemistry genre, including product MANAGING DIRECTOR development, marketing, finance and administration.
Slide 26: Global Footprint
GLOBAL FOOTPRINT © OMKAR SPECIALITY CHEMICALS LIMITED. STRICTLY PRIVATE & CONFIDENTIAL. NOT FOR CIRCULATION
Slide 27: Questions
VIDYUT KUMAR TA HEAD-INVESTOR RELATIONS B-34, M.I.D.C. Badlapur (East), District Thane, Maharashtra. Pin Code: 421503, India. Email: investor@omkarchemicals.com. Contact: + 91-8879041399 QUESTIONS BSE:533317 NSE:OMKARCHEMEQ BLOOMBERG: OSCL:IN REUTERS: OMKS.NS © OMKAR SPECIALITY CHEMICALS LIMITED. ST
Omkar Speciality Chemicals — Q3 FY2019 Earnings Presentation on 6ix